Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

    brain
    Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Investigators
  3. Investigator Site Resource Centre
  4. FAQs

FAQs

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

I recently received a lab report that indicated a specimen was "hemolyzed." What does that mean and what caused that to happen?

Hemolysis refers to the destruction of red blood cells which leads to the release of haemoglobin from within the cells. Hemolysis affects specimen quality and, consequently, can affect the results for certain laboratory tests. Site personnel can prevent hemolysis by avoiding the circumstances that can cause it. These include:

Too great a vacuum in the vein, causing the red cells to be drawn toward the bore of the needle too quickly. Also the red cells could be forced through too small an opening too quickly. Using too large a vacutainer tube on too small a vein.m Too slow a flow of blood into the tube, indicating that the flow is somehow obstructed (such as the opening of the needle being too close to the upper or lower lumen wall). Using too small a gauge needle for the vacuum applied to the blood collection system (be it variable by syringe or constant by vacuum draw system). Too large a gauge needle resulting in too great a vacuum pulling too much blood through the opening too quickly. Vigorous mixing or shaking of the filled collection tube. Not mixing an anticoagulated sample after it has been collected. Centrifuging an anticoagulated blood sample to check for hemolysis.

The lavender-top tubes that I sent to your laboratories could not be processed because the specimen clotted. How did this happen? What can be done to prevent clotting?

Specimen clotting usually occurs because the collected blood does not mix thoroughly with the EDTA preservative that is contained in the tube. To avoid this problem collect the specimen, then invert the tube 8-10 times at approximately a 180 angle (the equivalent of a semi-circle). This procedure will permit the EDTA to thoroughly mix with the specimen so that clotting does not occur. Also, do NOT store this type of sample at a refrigerated or frozen temperature prior to shipping. Your ICON Laboratories Investigator Manual provides step-by-step, illustrated instructions that should also be helpful in properly preparing this specimen.

Why do I have to prepare Peripheral Blood Film slides when sending a CBC with Differential to the lab? How do I properly prepare the slides?

Preparing and sending a quality Peripheral Blood Film is a critical procedure to ensure that accurate test results are reported for your study subject. When the specimen you collect for the a CBC with Differential arrives at our laboratory , the testing is performed on an automated instrument. If the instrument detects an abnormality, or requires confirmation, a laboratory technologist will perform what is known as a "manual differential." To ensure that the specimen abnormalities are not due to specimen transport issues or time delays, the laboratory relies upon slides made from freshly collected blood, prepared at the investigator site at the time of specimen collection. Since proper preparation of the Peripheral Blood Film slide is so important, we have provided a brief video that demonstrates the proper preparation procedures.View Video Here.

Does it matter how I place the bar code label on the collection tube?

YES! The bar code is the primary means of tracking the sample at our lab from the time of receipt through testing and storage. To ensure that it can be scanned appropriately the bar code should ALWAYS be affixed so that it is aligned with the tube (The bar code should not go around the tube.) It is also important that the label not cover the tube cap. Proper labeling facilitates scanning and prevents delays in reporting. Also, please remember to affix a bar code label in the designated place on each copy of the requisition to properly link the requisition to the samples submitted for that visit.

In this section
In this section
  • Company history
  • ICON at a glance
  • Patients
  • Volunteers
  • ICON in Asia Pacific
    • Japan
    • India
    • China
  • Investigators
    • Clinical Study Investigators
    • Early Phase
    • Investigator Site Resource Centre
      • Commercial invoices – UK clinical trial sites shipping to ICON Dublin
      • FAQs
      • Holiday Schedule
      • Lab Certificates
      • Packaging instructions
      • Site training
      • Track Shipment
      • iSite
      • LabView360
    • Register
      • Early Phase
    • Transparency - Loi Bertrand Legislation
      • Contact
      • La Réglementation
      • Les données de transparence
  • ICON in Latin America
  • Jobs & Careers
  • Investors
  • Leadership
    • Board of Directors
  • Quality
  • Suppliers
  • Environmental, Social and Governance
    • Environment
    • Governance
    • Social

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

Related information:

Factsheet

Investigators - Biosimilars FAQ

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence